Finner retningen …
Finner retningen …
MF9235
Laster botkontroll.
Gjennomsnittlig svar: ingen svar
Gjennomsnittlig svar: ingen svar
Gjennomsnittlig svar: ingen svar
Gjennomsnittlig svar: ingen svar
KARAKTERFORDELING · H 2025
7 kandidater
Kilde: Felles studentsystem (FS) via Universitetet i Oslo, slik den var publisert for høsten 2026. Universitetet i Oslo er ikke ansvarlig for innholdet på denne siden.
UiO sin egen emnebeskrivelse — læringsutbytte, innhold og vurderingsform.
This course focuses on the molecular mechanisms of cancer, combining textbook-based lectures, research discussions, student presentations, and lab visits to provide a comprehensive understanding of modern Cancer Biology, personalized medicine, and translational research. Students gain practical insights and up-to-date knowledge necessary for advancing in cutting-edge cancer research and therapy development.
The purpose of the course is to equip students with a solid foundation to work in the forefront of Cancer Research, and to provide a foundation for effective translational cancer research.
This is achieved by combining the following elements:
All teaching is conducted by active national and international researchers in molecular Cancer Biology.
Modern Cancer Biology research, translational research and personalized cancer medicine rely heavily on the molecular understanding of cancer. This course provides a state-of-the-art thorough overview of the current understanding of molecular Cancer Biology.
The course will give you knowledge about:
PhD candidates and master students can apply for this course.
Applicants admitted to a PhD programme at UiO sign up for classes and exam to this course in StudentWeb.
Applicants who are not admitted to a PhD programme at UiO must apply for a right to study before they can sign up for classes and exam to this course. See information here: How to apply for a right to study and admission to elective PhD courses in medicine and health sciences
Applicants will upon registration receive an immediate reply in StudentWeb as to whether a seat at this course is granted or not.
Maximum number of participants is 30.
The course is an intensive full two weeks course and consist of:
You have to participate in at least 80 % of the teaching to be allowed to take the exam. Attendance will be registered.
The exam consists of two parts that aim to test the students overall comprehension, overview and ability to criticallly evaluate current research within cancer biology.
The exam consists of:
Both parts must be passed to pass the course.
Kilde: Felles studentsystem (FS) via Universitetet i Oslo, slik den var publisert for høsten 2026. Universitetet i Oslo er ikke ansvarlig for innholdet på denne siden.
Hva burde andre vite før de tar dette? Anonymt, ingen innlogging.
Basert på hvor kandidatene til eksamen var registrert (DBH).
Emner som tas i de samme studieprogrammene som MF9235.
| Semester | Kandidater | Stryk |
|---|---|---|
| Høst 2025 | 7 | 0 % |
| Høst 2024 | 4 | 0 % |
| Høst 2023 | 7 | 0 % |
| Høst 2022 | 11 | 0 % |
| Høst 2021 | 10 | 0 % |
| Høst 2020 | 4 | 0 % |